In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies

Silvere Pagant, Rachel A. Liberatore

Open source

DOI
10.3390/pharmaceutics13111882
Published
2021-11-06
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics13111882,
  title = {In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies},
  author = {Silvere Pagant and Rachel A. Liberatore},
  year = {2021},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics13111882},
  url = {https://doi.org/10.3390/pharmaceutics13111882}
}

RIS

TY  - JOUR
TI  - In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies
AU  - Silvere Pagant
AU  - Rachel A. Liberatore
PY  - 2021
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics13111882
UR  - https://doi.org/10.3390/pharmaceutics13111882
ER  - 

APA

Pagant, S., & Liberatore, R. A. (2021). In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13111882

Source records